Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Yolk bioprotein foam filler and preparation method thereof

A biological protein and yolk protein technology, applied in the field of reproductive inflammation medicine, can solve the problems of destroying the physiological environment of the reproductive system, pathogens are prone to drug resistance, difficult to kill pathogens, etc., achieving high safety, preventing vaginal infections, reducing Effects of vaginal discharge volume

Inactive Publication Date: 2016-07-13
西安昱子生物科技有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional drugs will produce different degrees of side effects at the same time of treatment, it is difficult to selectively kill pathogenic bacteria, destroy the physiological environment of the reproductive system, and pathogens are prone to drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] A yolk biological protein foam filling agent, the main components are as follows in terms of mass percentage: 8% polylinked yolk protein, 0.1% preservative, 40% matrix, and the balance is foaming agent.

[0028] Wherein, the concatenated yolk protein is a yolk biological protein that can be combined with various pathogens, including but not limited to Ureaplasma urealyticum, Mycoplasma hominis, Staphylococcus, Streptococcus, Escherichia coli, Gardnerella vaginalis , Neisseria gonorrhoeae, Candida albicans. The preservative is ethyl p-hydroxybenzoate. Described foaming agent is K12 foaming agent.

[0029] The preparation method of the polylinked yolk protein is:

[0030] (1) Cultivate Ureaplasma urealyticum, Mycoplasma hominis, Staphylococcus, Streptococcus, Escherichia coli, Gardnerella vaginalis, Neisseria gonorrhoeae, and Candida albicans respectively with medium, and the obtained bacteria are inactivated with formaldehyde respectively, emulsified Oil-forming emuls...

Embodiment 2

[0040] A yolk biological protein foam filling agent, the main components are as follows in terms of mass percentage: 14% polylinked yolk protein, 0.2% preservative, 45% matrix, and the balance is foaming agent.

[0041] Wherein, the concatenated yolk protein is a yolk biological protein that can be combined with various pathogens, including but not limited to Ureaplasma urealyticum, Mycoplasma hominis, Staphylococcus, Streptococcus, Escherichia coli, Gardnerella vaginalis , Neisseria gonorrhoeae, Candida albicans. The preservative is butyl p-hydroxybenzoate. The foaming agent is AES foaming agent.

[0042] The preparation method of the polylinked yolk protein is:

[0043] (1) Cultivate Ureaplasma urealyticum, Mycoplasma hominis, Staphylococcus, Streptococcus, Escherichia coli, Gardnerella vaginalis, Neisseria gonorrhoeae, and Candida albicans respectively with medium, and the obtained bacteria are inactivated with formaldehyde respectively, emulsified Oil-forming emulsion i...

Embodiment 3

[0053] A egg yolk biological protein foam filling agent, the main components are as follows in terms of mass percentage: 20% polylinked egg yolk protein, 0.3% preservative, 50% matrix, and the balance is foaming agent.

[0054] Wherein, the concatenated yolk protein is a yolk biological protein that can be combined with various pathogens, including but not limited to Ureaplasma urealyticum, Mycoplasma hominis, Staphylococcus, Streptococcus, Escherichia coli, Gardnerella vaginalis , Neisseria gonorrhoeae, Candida albicans. The preservative is potassium sorbate. Described foaming agent is K12 foaming agent.

[0055] The preparation method of the polylinked yolk protein is:

[0056] (1) Cultivate Ureaplasma urealyticum, Mycoplasma hominis, Staphylococcus, Streptococcus, Escherichia coli, Gardnerella vaginalis, Neisseria gonorrhoeae, and Candida albicans respectively with medium, and the obtained bacteria are inactivated with formaldehyde respectively, emulsified Oil-forming em...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a yolk bioprotein foam filler which is mainly composed of 8-10% of multi-link yolk protein, 0.1-0.3% of preservative, 40-50% of matrix and the balance of a foamer.The multi-link yolk protein is yolk bioprotein capable of being combined with various pathogens, and the pathogens include, but not limited to ureaplasma urealyticum, mycoplasma hominis, staphylococcus, streptococcus, Escherichia coli, Gardnerella vaginalis, gonococcus and Tritirachium album.The yolk bioprotein foam filler is mainly composed of yolk bioprotein aiming at inhibiting pathogenic bacteria, can be combined with corresponding pathogens, can effectively inhibit and remove pathogens, is effective on most bacteria, mycete and mycoplasma, does not have impact on probiotics, can maintain health and physiological environment of a reproductive system, does not enter blood, is higher in safety during local use, is free of irritation and side effect on human body, dependency, drug resistance and hypersensitivity and can be used for various clinical therapeutic products for vaginitis.

Description

technical field [0001] The invention relates to the technical field of medication for reproductive inflammation, in particular to a yolk biological protein foam packing agent and a preparation method thereof. Background technique [0002] Reproductive inflammation is the most common inflammation of female reproductive organs, and it is a common disease in gynecological clinics. All ages can be affected. Mainly caused by urination and Mycoplasma hominis, Staphylococcus, Streptococcus, Escherichia coli, Gardnerella vaginalis, Neisseria gonorrhoeae, Candida albicans, etc. For normal healthy women, due to anatomical and biochemical characteristics, the vagina has a natural defense function against the invasion of pathogens; when the natural defense function of the vagina is destroyed, pathogens are easy to invade and cause vaginal inflammation. [0003] At present, the components of traditional compound lotions to inhibit pathogens (bacteria, mold, mycoplasma) are mainly tradi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/395A61K39/40A61P31/04A61P31/10A61P15/02
CPCA61K2039/54A61K2039/70C07K16/02C07K16/1203C07K16/1217C07K16/1232C07K16/1253C07K16/1271C07K16/1275C07K16/14C07K2317/31Y02A50/30
Inventor 黄威权赵锋高琪
Owner 西安昱子生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com